The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology Analysis Ozelle will unveil O-Cyte 1, our newest automated hematology analyzer, at ADLM 2026 in Anaheim, California. Making its global debut at one of the leading international events for diagnostics and laboratory medicine, O-Cyte 1 […]
For more than seventy years, hematology analysis has advanced through successive technological breakthroughs. From automated cell counting to multi-parameter flow cytometry and digital morphology, each generation of innovation has expanded how laboratories observe and understand blood. Yet one of the most information-rich dimensions of hematology has remained difficult to scale: cellular morphology. For decades, identifying
The Fourth Generation of Hematology Analysis Has Begun Lire la suite »
Why supply planning now matters as much as analyzer selection For many years, laboratory managers focused first on choosing analyzers and only later on the details of laboratory and analytical supplies. Today, this approach is no longer sustainable. Test cartridges, reagents, calibrators and quality‑control (QC) materials account for a large share of total cost of
How to Plan Laboratory and Analytical Supplies for AI Mini‑Lab Analyzers Lire la suite »
Ozelle has received a Gold Award at the German Innovation Award, one of Germany’s leading innovation honors, for its EHBT-50 Mini Lab Multi-Functional Analyzer. The award recognizes innovations that advance products and technologies through meaningful user value, engineering excellence, and practical impact across industries. Advancing Diagnostics Beyond Centralized Laboratories Designed for decentralized clinical settings, the
Across the Middle East and Eurasia, diagnostics is entering a decisive new phase — driven by rising testing demand, chronic disease burdens, and a strong push toward connected, value‑based care. Laboratories and clinics are under increasing pressure to deliver faster, smarter, and more standardized results while keeping costs and staffing under control. At Expomed Eurasia
Ozelle to Showcase AI‑Powered Hematology Analyzers at Expomed Eurasia 2026 Lire la suite »
When Installed Base Becomes the Growth Challenge Across many veterinary markets today, hematology analyzers are already widely installed in clinics. For one veterinary diagnostics distributor operating across several EMEA markets, this reality created an unexpected commercial challenge. For years, the distributor had built a successful business supplying hematology analyzers to small animal clinics. But by
In the rapidly evolving field of regenerative therapies, precision and consistency are everything. For a leading U.S. medical device company specializing in autologous platelet and stem cell concentration systems, platelet-rich plasma (PRP) therapy represents both a science and a promise — accelerating recovery by harnessing the body’s innate regenerative power. Yet its success hinges on
Alors que WHX Labs Dubai 2026 ouvre ses portes aujourd'hui, les visiteurs du stand S1.D58 sont invités à découvrir comment Ozelle transforme les tests de diagnostic en flux de travail interactifs et prêts à prendre des décisions. Sous le thème “AI × CBM : la nouvelle génération de la morphologie sanguine complète”, le système intégré combine l'analyse morphologique à haute résolution, les flux de travail assistés par l'IA et les panels prêts à l'emploi pour une prise de décision clinique en toute confiance, alimentée par un système d'analyse de la morphologie du sang.
Lors du WHX Labs Dubai 2026 (10-13 février, stand S1.D58), Ozelle présentera son système de diagnostic intelligent de nouvelle génération sous le thème “AI × CBM : la nouvelle génération de la morphologie sanguine complète”. Conçue pour faire évoluer les tests de diagnostic au-delà des analyseurs autonomes, la solution d'Ozelle intègre une analyse morphologique du sang alimentée par l'IA avec une architecture de système prête à l'emploi - faisant le lien entre une profondeur analytique de qualité laboratoire et la technologie de l'analyse de la morphologie du sang.
Voir au-delà du sang. Un aperçu de l'avenir. Düsseldorf, Allemagne - 17 novembre 2025 A MEDICA 2025 (Hall 1 | A23-H), Ozelle dévoile sa nouvelle génération de solution AI + Complete Blood Morphology (CBM), une innovation diagnostique tout-en-un qui combine l'hématologie, la biochimie et les tests immunologiques en un seul passage. Cette nouvelle solution incarne la vision d'Ozelle qui consiste à rendre les tests de diagnostic avancés plus faciles à réaliser.
Saisissez votre adresse électronique et nous vous enverrons un code de vérification pour réinitialiser votre mot de passe.
Français 
English 
Русский 
Español 
Deutsch 
Português 
العربية 
Italiano